Zynex: Abusive Pricing Model Unsustainable (NASDAQ:ZYXI)

September 28,2024

Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth.

Zynex: UnitedHealthcare Terminating Contract – An Undisclosed Loss That Accounts For 50%+ EBITDA – Night Market Research

Zynex (NASDAQ:ZYXI) shareholders have earned a 27% CAGR over the last five years

I Am A Bearish Bull On Zynex; It's Complicated (NASDAQ:ZYXI)

Zynex: Abusive Pricing Model Unsustainable (NASDAQ:ZYXI)

ZYNE - Zynerba Pharmaceuticals Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)

Zynex: Deteriorating Fundamentals And Signs Of Reimbursement Pressure ( NASDAQ:ZYXI)

Zynex (ZYXI): Letter Indicates UnitedHealthcare Is Terminating Contract – Undisclosed Loss

The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)

Zynex: Turnaround Nears Inevitable End – Largest Payor Cuts TENS Reimbursement, May Eliminate Earnings – Night Market Research

2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More)

The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)

Zynex: Seems An Odd Short Target (NASDAQ:ZYXI)

After the recent decline, Zynex, Inc. (NASDAQ:ZYXI) CEO Thomas Sandgaard's holdings have lost 17% of their value

I Am A Bearish Bull On Zynex; It's Complicated (NASDAQ:ZYXI)